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Cellular/Molecular
NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E
Displays Physiological Changes Associated with
Erythromelalgia and Paroxysmal Extreme Pain Disorder
Mutations and Produces Symptoms of Both Disorders
M. Estacion,1,2,3 S. D. Dib-Hajj,1,2,3 P. J. Benke,4 Rene H. M. te Morsche,5 E. M. Eastman,1,2,3 L. J. Macala,1,2,3
J. P. H. Drenth,5 and S. G. Waxman1,2,3
1Department of Neurology and 2Center for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, Connecticut 06510,
3Rehabilitation Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, 4Department of Genetics, Joe DiMaggio
Children’s Hospital, Hollywood, Florida 33021, and 5Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, 6500
HB Nijmegen, The Netherlands
Gain-of-function mutations of NaV1.7 have been shown to produce two distinct disorders: NaV1.7 mutations that enhance activation
produce inherited erythromelalgia (IEM), characterized by burning pain in the extremities; NaV1.7 mutations that impair inactivation
produce a different, nonoverlapping syndrome, paroxysmal extreme pain disorder (PEPD), characterized by rectal, periocular, and
perimandibular pain.Herewe report a novel NaV1.7mutation associatedwith amixed clinical phenotypewith characteristics of IEMand
PEPD, with an alanine 1632 substitution by glutamate (A1632E) in domain IV S4–S5 linker. Patch-clamp analysis shows that A1632E
produces changes in channel function seen in both IEM and PEPDmutations: A1632E hyperpolarizes (7 mV) the voltage dependence
of activation, slows deactivation, and enhances ramp responses, as observed in NaV1.7mutations that produce IEM. A1632E depolarizes
(17mV) the voltage dependence of fast inactivation, slows fast inactivation, and prevents full inactivation, resulting in persistent
inward currents similar to PEPDmutations. Using current clamp, we show that A1632E renders dorsal root ganglion (DRG) and trigem-
inal ganglion neurons hyperexcitable. These results demonstrate a NaV1.7 mutant with biophysical characteristics common to PEPD
(impaired fast inactivation) and IEM (hyperpolarized activation, slow deactivation, and enhanced ramp currents) associated with a
clinical phenotypewith characteristics of both IEMandPEPDand show that thismutation rendersDRGand trigeminal ganglionneurons
hyperexcitable. These observations indicate that IEM and PEPD mutants are part of a physiological continuum that can produce a
continuum of clinical phenotypes.
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Introduction
It is now clear that there are nine different isoforms of voltage-
gated sodium channels, all sharing a common overall motif but
with distinct amino acid sequences and different physiological
and pharmacological properties (Catterall et al., 2005). NaV1.7
sodium channels are unique in that they are preferentially ex-
pressed within primary sensory neurons of dorsal root (DRG)
and trigeminal ganglion and sympathetic ganglion neurons (Felts
et al., 1997; Sangameswaran et al., 1997; Toledo-Aral et al., 1997),
especially within nociceptors (Djouhri et al., 2003), and display
slow closed-state inactivation, a property that enables these chan-
nels to produce a depolarizing response to small slow depolariza-
tions that are subthreshold with respect to the action potential
(Cummins et al., 1998). The biophysical properties and subcel-
lular distribution of NaV1.7 suggest that it functions to boost
subthreshold stimuli, thereby setting the gain on nociceptors
(Waxman, 2006; Rush et al., 2007).
Over the past few years, NaV1.7 has assumed a prominent role
in pain research because mutations in this channel have been
linked to inherited human pain syndromes (Dib-Hajj et al., 2007;
Drenth andWaxman, 2007). Gain-of-function mutations (Yang
et al., 2004; Dib-Hajj et al., 2005; Drenth et al., 2005; Michiels et
al., 2005; Han et al., 2006; Lee et al., 2007) that shift activation of
NaV1.7 in a hyperpolarizing direction, slow deactivation, and
enhance ramp currents cause inherited erythromelalgia (IEM)
(Cummins et al., 2004; Dib-Hajj et al., 2005; Choi et al., 2006;
Han et al., 2006; Harty et al., 2006; Lampert et al., 2006; Sheets et
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al., 2007; Cheng et al., 2008), a disorder in which patients expe-
rience severe burning pain in the feet and, in most cases, in the
hands, in response tomild warmth and exercise. A different set of
gain-of-function mutations that impair inactivation of NaV1.7
and in some cases produce a persistent current (Fertleman et al.,
2006; Dib-Hajj et al., 2008; Jarecki et al., 2008) has been linked to
a different, nonoverlapping syndrome, paroxysmal extreme pain
disorder (PEPD), characterized by paroxysmal episodes of
burning pain in the rectal, ocular, and mandibular areas ac-
companied by autonomic manifestations such as skin flushing
(Fertleman et al., 2006). In contrast, loss-of-function muta-
tions of Nav1.7 have been linked to congenital inability to
experience pain (Cox et al., 2006; Ahmad et al., 2007; Gold-
berg et al., 2007).
In this paper, we describe and characterize a new mutation in
NaV1.7, A1632E, in a patient with a unique mixed clinical phe-
notype that includes characteristics of both IEM and PEPD. We
show that this mutation produces changes in channel function
that have been previously observed separately in both IEM and
PEPD, shifting activation in a hyperpolarizing direction, slowing
deactivation, and enhancing ramp currents as reported previ-
ously for IEM mutations and also impairing inactivation as pre-
viously reported for PEPD mutations. We also show that this
mutation produces hyperexcitability within both DRG and tri-
geminal ganglion neurons.
Materials andMethods
Patient. The patient is a Caucasian 10-year-old female with a life-long
pain syndrome with characteristics of both IEM and PEPD. The subject
and parents gave written informed consent, and the study was approved
by the Ethics Committee of the Hollywood Memorial Hospital (Holly-
wood, FL).
Exon screening. Genomic DNA was purified from venous blood.
Genomic DNA from 92 Caucasian individuals was used as a normal
population control. Coding exons and flanking intronic sequences, as
well as exons encoding 5 and 3 untranslated sequences within the
cDNA were amplified and sequenced as described previously (Drenth et
al., 2005). Genomic sequences were compared with the reference Nav1.7
cDNA (Klugbauer et al., 1995) to identify sequence variation.
Plasmid and stable cell line. The human NaV1.7 insert was cloned into
amammalian expression vector (Klugbauer et al., 1995) and converted to
become TTX-R (hNaV1.7R) by Y362S substitution (Herzog et al., 2003).
The A1632E mutation was introduced into hNaV1.7R using Quick-
Change XL II site-directed mutagenesis (Stratagene). Transfected HEK
293 cells, grown under standard culture conditions (5% CO2, 37°C) in
DMEM supplemented with 10% fetal bovine serum, were treated with
G418 for several weeks and stable cell lines that express themutant chan-
nel were selected. Cells for voltage-clamp recordings were sparsely sub-
plated onto 35 mm culture dishes.
Primary sensory neuron isolation and transfection. Dorsal root ganglia
and trigeminal ganglia fromSpragueDawley rat pups (postnatal day 1–5)
were isolated and then cultured using the same protocol. Dissected gan-
glia were placed in ice-cold oxygenated complete saline solution (CSS),
which contained the following (in mM): 137 NaCl, 5.3 KCl, 1 MgCl2, 25
sorbitol, 3 CaCl2, and 10 HEPES, pH 7.2. They were then transferred to
an oxygenated, 37°C CSS solution containing 1.5 mg/ml Collagenase A
(Roche Applied Science) and 0.6 mM EDTA and incubated with gentle
agitation at 37°C for 20 min. This solution was then exchanged with an
oxygenated, 37°C CSS solution containing 1.5 mg/ml Collagenase D
(Roche Applied Science), 0.6 mM EDTA, and 30 U/ml papain (Worth-
ington Biochemicals) andwas incubated with gentle agitation at 37°C for
20 min. The solution was then aspirated, and the ganglia were triturated
in DRG media [DMEM/F-l2 (1:1) with 100 U/ml penicillin, 0.1 mg/ml
streptomycin (Invitrogen), and 10% fetal calf serum (Hyclone), which
contained 1.5 mg/ml bovine serum albumin (Sigma-Aldrich) and 1.5
mg/ml trypsin inhibitor (Roche Applied Science)].
Either wild-type hNaV1.7R (WT) or hNaV1.7R –A1632Emutant chan-
nels were transiently transfected into the DRG or trigeminal ganglia neu-
rons, along with enhanced green fluorescent protein (GFP), by electro-
poration with aNucleofector II (Amaxa) using Rat NeuronNucleofector
Solution and program G-013. The ratio of sodium channel to GFP con-
structs was 5:1. The transfected neurons were allowed to recover for 5
min at 37°C in 0.5 ml of Ca2-free DMEM containing 10% fetal calf
serum. The cell suspension was then diluted with DRGmedia containing
1.5 mg/ml bovine serum albumin and 1.5 mg/ml trypsin inhibitor, 80 l
was plated on 12mmcircular poly-D-lysine/laminin precoated coverslips
(BD Biosciences), and the cells were incubated at 37°C in 5% CO2 for 30
min. DRG media (1 ml/well), supplemented with 50 ng/ml each of
mouse NGF (Alomone Labs) and glial cell line-derived neurotrophic
factor (Peprotec), was then added, and the cells were maintained at 37°C
in a 5% CO2 incubator.
Electrophysiology. Whole-cell voltage-clamp recordings were per-
formed using the following solutions. The extracellular solution con-
tained the following (in mM): 140 NaCl, 3 KCl, 1 MgCl2, 1 CaCl2, and 10
HEPES, pH 7.3 with NaOH (adjusted to 320 mOsm with dextrose). The
pipette solution contained the following (in mM): 135 Cs-aspartate, 10
NaCl, 2 MgCl2, 0.1 CaCl2, 1.1 EGTA, pCa 8, and 10 HEPES, pH 7.2 with
CsOH (adjusted to 310mOsmwith dextrose). Patch pipettes had a resis-
tance of 1–3Mwhen filledwith pipette solution. The junction potential
of 16 mV (calculated by JPcalc included in pClamp software) was com-
pensated by setting the holding potential during the seal test period to
16mV.Once the seal had formed, these two solutionswere no longer in
contact and the applied potential was correct. After achieving the whole-
cell recording configuration, the pipette and cell capacitance were man-
ually minimized using the Axopatch 200B (Molecular Devices) compen-
sation circuitry. To reduce voltage errors, 80–90% series resistance and
prediction compensation was applied. Cells were excluded from analysis
if the predicted voltage error exceeded 3mV. The recorded currents were
digitized using pClamp software (version 10) and a Digidata 1440A in-
terface (Molecular Devices) at a rate of 50 kHz after passing through a
low-pass Bessel filter setting of 10 kHz. Linear leak and residual capaci-
tance artifacts were subtracted out using the P/Nmethod provided by the
Clampex software. The Na-current recordings were initiated after a 5
min equilibration period once whole-cell configuration was achieved.
Data analysis was performed using Clampfit (Molecular Devices) or
Origin (Microcal Software). To generate activation curves, cells were
held at100 mV and stepped to potentials of80 to40 mV in 5 mV
increments for 100 ms. Peak inward currents obtained from activation
protocols were converted to conductance values using the equation,G
I/(Vm  ENa), for which G is the conductance, I is the peak inward
current, Vm is the membrane potential step used to elicit the response,
and ENa is the reversal potential for sodium (determined for each cell
using the x-axis intercept of a linear fit of the peak inward current re-
sponses). Conductance data were normalized by the maximum conduc-
tance value and fit with a Boltzmann equation of the form G Gmin
(Gmax Gmin)/(1 exp[(V1/2 Vm)/k)], where V1/2 is the midpoint of
activation, and k is a slope factor. To generate steady-state fast inactiva-
tion curves, cells were stepped to inactivating potentials of170 to30
mV for 500 ms followed by a 20 ms step to 20 mV. The protocol for
slow inactivation consisted of a 30 s step to potentials varying from120
to 10 mV, followed by a 100 ms step to120 mV to remove fast inacti-
vation and a 20 ms step to 0 mV to elicit a test response. Peak inward
currents obtained from steady-state fast inactivation and slow inactiva-
tion protocols were normalized by the maximum current amplitude and
fit with a Boltzmann equation of the form I Imin (Imax Imin)/(1
exp[(Vm  V1/2)/k)], where Vm represents the inactivating prepulse
membrane potential, and V1/2 represents the midpoint of inactivation.
Decaying currents were fit with a single-exponential equation of the form
I A * exp(t/) Ic, where A is the amplitude of the fit, t is time,  is
the time constant of decay, and Ic is the asymptotic minimum to which
the currents decay. Data are expressed as means  SEM. Statistical sig-
nificance was determined by Student’s t test.
Whole-cell current-clamp recordings were performed using the Axo-
patch 200B amplifier, digitized using the Digidata 1440A interface, and
controlled using pClamp software. The bath solution for current-clamp
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recordings contained the following (inmM): 140 NaCl, 3 KCl, 1MgCl2, 1
CaCl2, and 10 HEPES, pH 7.3 with NaOH (adjusted to 315 mOsm with
dextrose). The pipette solution contained the following (in mM): 140
KCl, 0.5 EGTA, 5 HEPES, and 3Mg-ATP, pH 7.3 with KOH (adjusted to
300 mOsm with dextrose). The junction potential between these two
solutions given by JPcalc was 5 mV, but no correction was applied for
current-clamp experiments. Recordings were performed on transfected
presumptive nociceptive neurons based on the morphology of small-
diameter (20–28 m) round cell bodies that also exhibited GFP fluores-
cence. All recordings were performed between 20 and 30 h after transfec-
tion. Coverslips were transferred to a perfusable chamber (Warner
Instruments) and all recordings were initiated within 1 h. Whole-cell
configuration was obtained in voltage-clampmode before proceeding to
the current-clamp recording mode. Cells with stable (10% variation)
resting membrane potentials (RMPs) more negative than 35 mV and
overshooting action potentials (85 mV RMP to peak) were used for
additional data collection. Input resistance was determined by the slope
of a line fit to hyperpolarizing responses to current steps of 10–35 pA.
Threshold was determined by the first action potential elicited by a series
of depolarizing current injections that increased in 5 pA increments.
Action potential frequencywas determined by quantifying the number of
action potentials elicited in response to depolarizing current injections of
1 s duration.
Results
Clinical phenotype and identification of the A1632E mutation
The patient presented with apnea, bradycardia, and poor feeding
since birth. Severe reflux, projectile vomiting, and a hypersensi-
tive gag reflex required a fundoplication and gastrostomy tube for
management. Bradycardic episodes, in which the patient would
turn blue and sometimes required cardiopulmonary resuscita-
tion, were precipitated by touching or stimulation such as eating,
voiding, or bowel movements, and required insertion of a pace-
maker at 18 months of age. Rectal sensitivity continued and epi-
sodes of periodic pain and erythema developed as the patient
grew older. After age 3, the patient developed almost daily attacks
of (1) unilateral eye, jaw, or facial discomfort and redness, (2)
episodes of harlequin (half-face) redness and facial pain, (3)
stomach pain, vomiting, or breath-holding spells, and (4) tran-
sient episodes of pain described as “hot needles” and erythema in
the feet, hands, and head, often precipitated by warmth or being
touched, and attenuated by cooling. The parents and a half sib-
ling are asymptomatic.
Amplification and direct sequencing of all exons of SCN9A
identified a heterozygous 4895C Amutation in exon 26 in the
index patient, which predicts amino acid substitution A1632E in
NaV1.7. The mutation was not present in the unaffected father
andmother, suggesting that this mutation appeared de novo. The
4895C A mutation was absent in 92 unrelated healthy control
subjects of the same ethnic origin. The A1632E mutation alters a
highly conserved amino acid within the linker between trans-
membrane segments S4 and S5 of domain IV (Fig. 1). The amino
acid sequence of this loop is highly conserved among all sodium
channels except Nav1.9, in which the residue corresponding to
A1632 is replaced by a serine (Fig. 1). Nav1.9 shows the most
sequence variability compared with the other members of the
sodium channel gene family (Dib-Hajj et al., 1998).
Voltage-clamp recordings fromHEK 293 cells stably
expressingWT or A1632Emutant hNaV1.7R channels
Whole-cell voltage-clamp recordings were performed on clonal
cell lines expressing either WT or A1632E channels. The activa-
tion properties of the currents expressed by these cells were tested
by holding the cells at 100 mV and then applying 100 ms test
pulses to potentials between 80 and 40 mV in 5 mV incre-
ments. Inward currents recorded by this protocol are shown for
WT (Fig. 2A) and A1632E (Fig. 2B) channels. The average peak
inward current was smaller for A1632E cells (0.95 11 nA; n
18) compared with WT cells (3.21  0.41 nA; n  9). This dif-
ference was maintained when normalized for capacitance to give
a significant reduction in current density from the A1632E cells
compared withWT cells (30.5 3.8 pA/pF for A1632E; 152 23
pA/pF for WT; p 0.001). The amplitude of the current in HEK
293 cells transiently transfected with A1632E mutant channels
was also smaller than that ofHEK 293 cells transiently transfected
with WT channels (data not shown), suggesting that the smaller
current in the stable lines was not caused by the site of integration
of the construct.
Time-to-peak and rate of deactivation
Examination of themean time-to-peak (Fig. 2C) revealed a small
increase in the time-to-peak for A1632E currents compared with
WT currents, which was significant over the voltage range be-
tween 5 to 30 mV. An additional test for altered activation
properties is to examine the deactivation kinetics as open chan-
nels transition back to the closed state. Single-exponential fits of
the current decay (to measure time constant) showed that the
A1632E channels close significantly more slowly over the entire
voltage range from100 to40 mV (Fig. 2D)
Voltage dependence of activation and fast inactivation
The voltage dependence of activation and fast inactivation was
examined by transforming the peak current versus voltage ( I–V)
curves into conductance versus voltage (G–V) curves as de-
scribed in Materials and Methods. The G–V curve was fit to a
Boltzmann function that directly gives the voltage midpoint
(V1/2) as well as the slope factor (k) of the voltage-dependent
response. The Boltzmann fits for both activation and fast inacti-
vation were derived for each cell individually. The averages of the
normalized G–V curves for activation and fast inactivation for
both A1632E and WT channels are illustrated in Figure 2E. The
average of the fits for fast inactivation revealed that, like other
PEPD mutant Na channels, the V1/2 for A1632E channels was
significantly shifted in the depolarizing direction compared with
Figure 1. Sequence alignment of DIV/S4–S5 linker from human sodium channels. Sche-
matic of the topology of the sodium channel polypeptide showing the location of the A1632E
near the C-terminal end of the linker joining segments S4 and S5 in domain IV. The A1632E
substitution is noted in the sequence from NaV1.7. The equivalent residue is conserved in all
sodium channels except for NaV1.9, in which the analogous residue is a serine (S1496).
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WT (63.9 0.9 mV for A1632E, n 18;
80.9  1.4 mV for WT, n  9; p 
0.001). In addition to this 17 mV shift in
the depolarizing direction, the slope factor
for A1632E fast inactivation became sig-
nificantly steeper (5.61 0.31 for A1632E;
8.13 0.36 for WT; p 0.001).
Comparing the average of the fits for
the voltage dependence of activation re-
vealed a shift, similar to the shift seen for
other IEM mutations but not previously
reported for PEPDmutations, of the mid-
point of activation by theA1632E channels
of 7 mV in the hyperpolarizing direction
(33.3 0.6mV forA1632E;26.2 1.6
mV for WT; p 0.001).
Closer examination of the Boltzmann
curves fitted to the averages for theA1632E
displayed offsets from zero for both activa-
tion and inactivation (Fig. 2E). The offset
from zero for activation was unexpected
but was probably attributable to the low
peak currents in A1632E-expressing cells,
because the analysis finds peak inward cur-
rents and the offset represents actual cur-
rents of only 20–30 pA in reference to 1 nA
Imax, whichwas similar to bandwidth noise
when using 10 kHz filtering. To display the
window current predicted by the overlap
of the activation and fast inactivation
curves, the offset from zero determined
from the fit of the activation G–V data
were subtracted from both the activation
and fast inactivation curves to account for
the effect of small total Imax values. Even
after this correction, the offset from zero
for A1632E fast inactivation appears to re-
flect an actual fraction of channels that
failed to inactivate as demonstrated in Fig-
ure 4. The depolarizing shift of fast inacti-
vation and the hyperpolarizing shift of ac-
tivation for A1632E channels compared
withWT channels results in a substantially
increased predicted window current (Fig.
2F).
Slow inactivation
Inactivation of Nav1.7 channels occurs
with at least two different time courses. In
addition to the fast (10–100 ms) inactiva-
tion process, there is an additional inacti-
vation process (slow inactivation) that de-
velops over a much longer time frame
(1–10 s). To determine whether the
A1632E mutation altered the slow-
inactivation process, cells were held at a
potential between 120 and 10 mV for
30 s to allow full development of both fast
and slow inactivation. A 100 ms pulse to
120 mV was used to recover from fast
inactivation, followed by a depolarizing
pulse to 0 mV to activate the available
channels. As illustrated in Figure 3A, the
Figure 2. A1632E shifts activation and fast inactivation.A,B, Typical data traces recorded fromHEK cell lines expressing either
theWT (A) or the hNaV1.7r–A1632Emutant (B) sodium channel. The current densities from the A1632E-expressing cell linewere
lower, with total peak inward currents averaging just under 1 nA. In comparison, the hNaV1.7r-WT clone total peak current
averaged near 3 nA. For display purposes, the traces were digitally filtered to 2 kHz. C, The average time-to-peak for the traces
recorded during the activation protocol are plotted as a function of test potential with theWT (n 9) responses shown by open
circles and the A1632E (AE) (n 18) responses are shown by filled circles. Error bars areSEM. D, Deactivation kinetics are
derived from single-exponential fits to tail currents recorded in response to brief activating pulses (0 mV for 0.5 ms), followed by
a repolarization to the indicated potential. Example data traces comparing the deactivation during repolarization to50mV are
shown in the inset. The time constants are averaged and plottedwith theWT (n 9) shownby open circles and the A1632E (n
7) shown by filled circles. Error bars areSEM. E, The peak inward currents elicited using either the activation or the fast-
inactivation protocol were transformed into normalized conductance as described in Materials and Methods, and the average
response at each test voltage was plotted using open symbols for WT (n 9) and filled symbols for A1632E (n 18). The
activationdata are plottedusing circles and the fast-inactivationdata are plottedusing squares. Error bars areSEM. The smooth
lines are Boltzmann fits to the average values. The small offset of the activation curve is a result of the small total currents recorded
from A1632E-expressing cells so that the peak inward current obtained from the baseline fluctuations represents a few percent-
age of Imax. The baseline offset from the fit of the A1632E inactivation data, however, likely corresponds to an incomplete
inactivation resulting in persistent current. F, The predicted window current is larger for A1632E (solid lines) compared with WT
(dashed lines).
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voltage dependence of slow inactivation for A1632E channels was
altered compared with WT channels. Boltzmann fits revealed
that, although themidpoint of slow inactivation is similar (66.7
mV forWT;63.2mV for A1632E), the slope was steeper for the
A1632E channels compared with WT (9.56 vs 17.37), and,
similar to fast inactivation, there was a fourfold increase in the
fraction of channels that appear resistant to the slow inactivation
process (0.203 for A1632E vs 0.05 for WT).
Recovery from inactivation
Recovery from inactivation (repriming) occurs at different rates
for specific channel subtypes, and the rate and extent of recovery
is voltage dependent. This repriming of the channels was mea-
sured using a two-pulse protocol and varying the interpulse in-
terval as well as the interpulse potential. The cell was first pulsed
to 0 mV for 20 ms to allow complete fast inactivation and then
repolarized to a specified potential for a range of durations to
allow channel recovery, which is quantified as the ratio of the
current evoked by the second pulse to 0 mV compared with the
response to the first pulse. The rate and extent of recovery, com-
paring A1632E and WT channels for three different interpulse
potentials, are shown in Figure 3B. At hyperpolarized interpulse
potentials such as shown for100 mV, the rate of recovery was
rapid and was similar between A1632E and WT channels. For
interpulse potentials of80 and60mV, however, both the rate
and the fraction of current recovered were larger for A1632E
channels compared with WT channels.
Persistent currents
For both the fast inactivation and the slow inactivation protocols,
the A1632E channels exhibited a fraction of channels resistant to
inactivation. Non-inactivating channels could result in persistent
sodium currents. The fraction of persistent current seen from
A1632E-expressing cells was evaluated in two ways, by determin-
ing the offsets after fitting inactivation with an exponential func-
tion or by comparing the current that persists at 100 ms after
onset of depolarization. The inactivation decay from A1632E
cells, obtained by fitting with a single-exponential function, con-
sistently needed an offset constant. The rate of fast inactivation as
a function of stimulus pulse potential is shown in Figure 4A,
which shows that the kinetics of A1632E channels are signifi-
cantly slowed over the voltage range between25 and35 mV.
Examples of traces showing the difference in inactivation be-
tweenWT and A1632E currents and the persistent current at 100
ms are shown in Figure 4B–D. With pulses to 20 mV, which
was near the voltage for peak current, the A1632E current de-
cayed more slowly thanWT and did not decay to zero. The same
two traces at the end of the depolarization pulse are displayed at
4
normalized by the amplitude of the response to the inactivation step and plotted as a function
of recovery period duration. The averages for cells expressingWT channels (open symbols; n
7) and A1632E channels (filled symbols; n 8) are shown with error barsSEM. Single-
exponential functions were fit to these averaged data and are shown by solid lines for A1632E
and dashed lines for WT. C, This panel illustrates the responses to a ramp pulse protocol that
spans the range of100 to 20mVover 600ms (0.2mV/ms). The response has been rescaled as
the percentage of peak inward current recorded during the activation I–V protocol. The peak
currents from wild-type hNaV1.7 are much larger than from the A1632E-expressing cells, thus
scaling the noise to be quieter. In addition, for display purposes, the WT trace has been post-
acquisition filtered to 1 kHz, and the A1632E trace has been post-acquisition filtered to 500 Hz.
The average peak ramp current from the A1632E cells was 4.2 0.3% at44.7 0.7 mV
(n  12), whereas the peak ramp current from the WT cells averaged 0.77  0.05% at
39.8 0.7 mV (n 9). Error bars are 1 SD.
Figure3. A1632Emutation effects slow-inactivation, repriming, and slow ramp currents.A,
The slow-inactivation protocol consists of a 30 s conditioning pulse, followed by a 100ms pulse
to120mV to restore the fast-inactivation state and then pulsed to 0mV for 50ms to activate
the fraction of available channels. The A1632E data (filled circles; n 5) show greater avail-
ability at all potentials comparedwithwild-type (open circles; n 5)with the difference being
greatest in the voltage range of 90 to 70 mV. In addition, there is a more prominent
fractionof channels that donotbecomeslow inactivatedat thepotentialsmorepositive to20
mV. The smooth lines are Boltzmann fits with the following parameters: WT: Imax 0.99, Imin
0.058,V1/266.7mV, and k17.4; A1632E: Imax1.0, Imin0.2,V1/263.2mV,
and k 9.5. B, The A1632E mutation alters recovery from fast inactivation. From a holding
potential of100 mV, fast inactivation was initiated by a step to 0 mV for 20 ms, followed by
a hyperpolarizing step to a recovery potential that varied in time (2–400 ms) and amplitude
(100 to60mV). The recovery periodwas followed by a second depolarizing test pulse to 0
mV. For each recovery potential, the peak inward current in response to the test pulse was
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higher gain in the inset, which clearly
shows that the A1632E current has per-
sisted for at least 100 ms (Fig. 4B). With
pulses to 15 mV, whereas the inactiva-
tion rate forWTchannels has continued to
speed up, the inactivation rate for A1632E
channels appears to have leveled off (Fig.
4C); the inset shows that, even at this po-
tential, the A1632E current has persisted
for at least 100 ms. If the A1632E channels
exhibit persistent currents in the sub-
threshold range, this could contribute to
neuronal hyperexcitability. Figure 4D
shows the response of WT and A1632E
channels to a pulse to 50 mV, and once
again the inset shows that A1632E current
persists to at least 100 ms.
Quantification of the A1632E persis-
tent current can be achieved by either fit-
ting exponential functions or measuring
the mean current for a 10 ms window near
the end of the 100ms activation pulse. Us-
ing eithermethod, the peak persistent cur-
rent averaged 	4% of the peak current
from the I–V curve for each A1632E cell.
Ramp responses
We evaluated the response of WT and
A1632E channels to small slow depolariza-
tions using a slow ramp protocol that
starts from a holding potential of 100
mV and steadily increases the applied po-
tential to20 mV over 600 ms for a ramp
rate of 0.2 mV/ms. This slow rate fully in-
activates many voltage-gated sodium
channels, but NaV1.7 and many disease-
causing NaV1.7 mutations still respond to
this protocol. To compare between cells,
the response is normalized to the peak in-
ward current recorded during the activa-
tion I–V protocol. The response of the
A1632Emutant compared withWT chan-
nels is shown in Figure 3C. The peak of the
slow ramp response of A1632E-expressing
cells averaged 4.2%, which is a fivefold in-
crease over the average ramp response of
0.77% inWT-expressing cells. In addition,
the slow ramp response from A1632E-
expressing cells typically showed a shoul-
der after the peak response that is consis-
tent with a small fraction of channels
persistently staying open.
Current-clamp recordings: DRG neurons
To assess the effect of the A1632E mutation on excitability, DRG
neurons were transfected with either the WT or A1632E con-
struct, and current-clamp recording conditions were used to de-
termine RMP, action potential threshold, and firing frequency in
small (22–28m)DRGneurons. The average size of the recorded
DRG neurons was 25.4  0.2 m (n  30) for WT-transfected
and 25.3  0.4 m (n  28) for A1632E-transfected cells. The
RMPwas56.8 1.1mV forWT cells and was54.2 2.7mV
for A1632E cells. This small depolarization of A1632E RMP was
not statistically significant. The input resistance was also similar
between groups (719  71 M for WT; 695  90 M for
A1632E). The main difference between these two groups was a
reduction of current threshold for single action potentials for the
A1632E-transfected cells (200 36 pA for WT; 132 22 pA for
A1632E; p 0.05).
The firing of action potentials of a representativeDRGneuron
transfected with either WT or A1632E is shown at threshold cur-
rent stimuli (Fig. 5A,B) and at current injections (1 s duration)
near two and three times threshold as well as the current injection
Figure 4. Fast inactivation is slowed and incomplete in A1632E-expressing cells. A, The decaying phase of the inward sodium
current elicited by the activation protocol was fit to a single-exponential for the voltage range of35 to35 mV. The average
time constant is plotted as a function of voltage forWT cells (open circles; n 8) and for A1632E cells (filled circles; n 18) Error
bars areSEM.B, Example traces elicited by pulses to20mV are shown superimposed and normalized to peak inward current
to illustrate the difference in inactivation rate betweenWT-expressing (gray line) andA1632E-expressing (black line, arrow) cells.
The end of the 100 ms trace (which was cutoff in the main panel to illustrate kinetics) is shown as an inset with an expanded
vertical axis to showthatA1632E current (black line, arrow)persists for at least 100ms.C, Example traces elicitedbypulses to15
mV are superimposed and normalized to peak inward current to illustrate the greater difference in inactivation rate at this
depolarizedpotential. The inset shows that, evenat this depolarizedpotential, persistent current can still be resolved fromA1632E
cells. D, Example traces elicited by pulses to 50 mV (nearer to RMP range and near threshold for voltage activation) are
superimposed and normalized to peak inward current to illustrate that persistent current is resolvable in this voltage range (inset,
black line, arrow). Note the expanded scale in D. For display purposes, the WT traces were digitally filtered to 2 kHz in the main
panels and filtered to 1 kHz in the insets, whereas the A1632E traces were digitally filtered to 1 kHz in themain panels of B and C
and filtered to 500 Hz in D and all insets.
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that elicited the maximal number of action potentials (Fig. 5C–
H). At threshold, there was no difference in either the average
action potential peak depolarization (58.8  1.8 mV for WT;
54.6  2.8 mV for A1632E) or the peak afterhyperpolarization
(AHP) (63  1.6 mV for WT; 63  1.5 mV for A1632E).
Figure 5, C–E, shows representative WT-transfected DRG neu-
rons that producemostly single action potentials in response to a
1 s depolarization with an occasional second or third spike elic-
ited by strong stimuli. A1632E-transfectedDRGneurons, in con-
trast, commonly generated multiple action potentials. To com-
pare the responses ofDRGneurons transfectedwith eitherWTor
A1632E sodium channels, the number of spikes elicited for cur-
rent injections ranging from 50 to 500 pA in 50 pA steps were
averaged together and plotted in Figure 6A. For each stimulus
level, the A1632E-transfected DRG neurons responded with sig-
nificantly more spikes compared with WT.
Current-clamp recording: trigeminal
ganglion neurons
The A1632E mutation was found in a pa-
tient whose clinical phenotype includes
pain in the periocular and mandibular re-
gions of the face. Because these areas are
innervated by sensory neurons that reside
in the trigeminal ganglion, we asked
whether the A1632E mutation would in-
duce hyperexcitability in those neurons.
To assess the effect of the A1632E muta-
tion on excitability, current-clamp record-
ing was used to determine RMP, action
potential threshold, and firing frequency
in small (22–28 m) rat trigeminal gan-
glion neurons that were transfected with
either the WT or A1632E construct. The
average size of the recorded trigeminal
ganglion neurons was 23.8 0.5m (n
27) for WT-transfected cells and 24.4 
0.5 m (n  27) for A1632E. The RMP
was 52.8  1.5 mV for WT cells and
52.9  1.5 mV for A1632E cells. The
only significant difference was for input
resistance (720 102 M for WT; 516
26M for A1632E; p 0.05). There was a
trend toward reduction of current thresh-
old for the A1632E-transfected cells
(166  21 pA for WT; 144  24 pA for
A1632E), but it did not reach statistical
significance.
Similar to DRG neurons, representa-
tive trigeminal ganglion neurons trans-
fected with eitherWT or A1632E channels
are shown to illustrate the response at
threshold (Fig. 7A,B) as well as the re-
sponse to current injections near two and
three times threshold and to stimuli elicit-
ing the maximal response (Fig. 7C–H). At
threshold, there was no difference in either
the average action potential peak depolar-
ization (55.2 3.0 mV forWT; 55.8 2.5
mV for A1632E) or the peak AHP
(58.2  1.6 mV for WT; 59.9  1.0
mV for A1632E). As shown in Figure 6B,
trigeminal ganglion neurons transfected
with A1632E responded with more spikes
than neurons transfected with WT as measured at each stimulus
level.
Discussion
In this study, we have identified a newmutation (A1632E) of the
NaV1.7 sodium channel in a patient with a painful disorder that
includes clinical characteristics of both IEM and PEPD. Previ-
ously described IEM mutations all shift activation in a hyperpo-
larizing direction and slow deactivation, and many of these mu-
tations enhance the NaV1.7 ramp current (Dib-Hajj et al., 2007).
Computer simulations suggest that the shift in activation is the
largest contributor to DRG neuron hyperexcitability (Sheets et
al., 2007). In contrast, previously described PEPD mutations of
NaV1.7 impair inactivation but have not been described as affect-
ing activation or deactivation (Fertleman et al., 2006; Jarecki et
al., 2008). We show here that the A1632E mutation has a mixed
Figure 5. Current-clamp recordings in transfected DRG neurons. The A1632Emutation decreases action potential threshold in
small, current-clamped DRG neurons. A, Responses of a current-clamped DRG neuron transfected with hNaV1.7r–WT DNA to a
series of subthreshold and suprathreshold depolarizing current stimuli stepped in 5 pA increments. Two traces are displayed that
show the threshold value for eliciting an action potential. RMP for this cell was56mV and thresholdwas 165 pA.B, Two traces
are displayed that show the threshold value for a DRG neuron transfectedwith hNaV1.7r–A1632E DNA. RMP for this cell was57
mV and threshold was 55 pA. Example action potential responses from DRG neurons transfected with hNaV1.7r–WT and
hNaV1.7r–A1632E DNA. C–E illustrate the responses elicited at currents approximately two and three times threshold as well as
the stimuli that elicited themaximal response for DRG neurons transfected with hNaV1.7r–WT DNA. F–H show the responses for
DGR neurons transfectedwith hNaV1.7r–A1632E DNA. These cells are the same as shown inA andB to determine action potential
threshold.
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physiological profile, with properties characteristic of both IEM
and PEPD mutations. Using voltage-clamp recordings, we dem-
onstrate that A1632E impairs fast inactivation, which is shifted 17
mV in a depolarizing direction, and slows fast inactivation, which
is incomplete, resulting in persistent inward currents. We also
demonstrate that A1632E produces a 7 mV hyperpolarizing shift
in activation, slows deactivation, accelerates repriming, and in-
creases the depolarizing response to slow ramp stimuli. Using
current clamp, we demonstrate that A1632E increases the fre-
quency of firing in response to suprathreshold stimuli, in both
DRG and trigeminal ganglion neurons.
The length and sequence of the S4–S5 linker in domain IV,
which carries the A1632E mutation, are highly conserved among
most sodiumchannels described to date, suggesting an important
role in normal channel function. Indeed, NaV1.4 channels with
small insertions at two sites in this linker do not generate sodium
currents (Mitrovic et al., 1996). Mutations in this linker have
been identified in NaV1.1 from patients with severe myoclonic
epilepsy of infancy (Claes et al., 2003; Nabbout et al., 2003), in
NaV1.4 with diseases of skeletal muscle (Mitrovic et al., 1996;
Fleischhauer et al., 1998; Rossignol et al., 2007; Schoser et al.,
2007), and inNaV1.5 with cardiac disorders (Ruan et al., 2007). It
is noteworthy that the A1632E mutation in NaV1.7 in this child
with a chronic pain disorder is analogous to the A1481D muta-
tion in NaV1.4 reported with cold-aggravatedmyotonia (Schoser
et al., 2007). It remains to be seen whether the effects of A1481D
on gating properties ofNaV1.4 are similar to the effects of A1632E
on NaV1.7.
The A1632Emutation is located within theDIV/S4–S5 linker,
close to the PEPD mutation M1627K (Fertleman et al., 2006),
suggesting a possible explanation for the effect of A1632E on
NaV1.7 gating properties. Although a large shift of fast-
inactivation voltage dependence is produced by both M1627K
(Fertleman et al., 2006; Dib-Hajj et al., 2008) and A1632E (this
study), the impairment of inactivation is smaller than with
I1461T and T1464I PEPD mutations of the IFMT inactivation
particle, which show amore substantial non-inactivating (persis-
tent) inward current (Fertleman et al., 2006). Why the M1627K
and A1632Emutations are better tolerated is not yet understood.
The possibility that these mutations influence S4–S5 linker fold-
ing and therefore affect inactivation (Tang et al., 1996; Lerche et
al., 1997; Smith and Goldin, 1997; McPhee et al., 1998) merits
additional study.
An alanine residue is conserved at the site corresponding to
A1632 in all sodium channels except NaV1.9, a channel charac-
terized by hyperpolarized voltage dependence of activation and
very slow inactivation, causing a persistent current (Cummins et
al., 1999; Dib-Hajj et al., 1999), in which it is replaced by a serine
(Fig. 1). It is possible that substitution of a serine for alanine in the
DIV/S4–S5 linker contributes to these properties of NaV1.9. Sur-
prisingly, a double mutation in NaV1.5 (P1655Q/A1656Q),
which includes the site analogous to A1632 in NaV1.7, had no
effect on the activation voltage dependence or the kinetics of
inactivation but shifted inactivation in a hyperpolarized direction
(Tang et al., 1998). However, it is difficult to assess the contribu-
tion of this residue to the gating properties of NaV1.5, because the
single A1656Qmutation was not studied. A1632S substitution in
NaV1.7, which recapitulates the sequence of this linker inNaV1.9,
does not induce major shifts in activation or inactivation as seen
with A1632E (data not shown). This suggests that a serine is
better tolerated than a glutamate at this position. The mutant
phenotype may be caused by the presence of a charge that desta-
bilizes the inactivation complex, biasing the channel toward the
activated/open state.
PEPD and IEM display distinct clinical phenotypes, with
PEPD characterized by paroxysmal pain in a rectal, periocular,
and perimandibular distribution, and IEM characterized by pain
in the feet and, in most cases, the hands. Previously described
PEPD mutations have been shown to impair inactivation and
have not been reported to affect activation or deactivation
(Fertleman et al., 2006; Jarecki et al., 2008). In contrast, muta-
tions linked to IEM have been observed to hyperpolarize activa-
tion and slow deactivation, either without an effect on inactiva-
tion (Cummins et al., 2004; Choi et al., 2006; Lampert et al., 2006;
Sheets et al., 2007; Cheng et al., 2008) or coupled to a shift in
inactivation voltage dependence, which was, nevertheless, com-
plete (Dib-Hajj et al., 2005; Han et al., 2006; Harty et al., 2006).
The shifts of voltage dependence of activation and fast inactiva-
tion for these PEPD and IEMmutants are illustrated in Figure 8.
The PEPD and IEM mutations characterized to date exhibit dis-
tinct nonoverlapping groupings of electrophysiological proper-
Figure 6. A1632E expression increases excitability in DRG and trigeminal ganglion neurons.
The mean number of action potentials (defined as action potentials that overshoot 0 mV) is
quantified in response to a series of 1-s-long current injections ranging from 50 to 500 pA in 50
pA increments. A, The mean response was significantly higher ( p 0.05) for DRG neurons
transfected with hNaV1.7r–A1632E (AE) (n 28) compared with WT (n 30) at every stim-
ulus level. Error bars areSEM. B, The mean response reached significance ( p 0.05) for
trigeminal ganglion neurons (TG) transfectedwith hNaV1.7r–A1632E (n 27) comparedwith
WT (n 27) for current injections between 200 and 350 pA. Error bars areSEM.
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ties that correlate to and possibly predict their clinical
phenotypes.
The A1632Emutation is associated with a mixed clinical phe-
notype that includes features of both PEPD (pain in perirectal,
perimandibular, and periorbital areas) and erythromelalgia (pain
in feet and hands). In parallel, A1632E exhibits a functional pro-
file that includes electrophysiological properties characteristic of
both PEPD and IEM (Fig. 8). As illustrated in this figure, com-
parison of the previously published IEM and PEPD mutations
suggests that hyperpolarizing shifts in activation produce IEM,
whereas depolarizing shifts in fast inactivation produce PEPD.
The A1632Emutant provides evidence, in humans, that a NaV1.7
mutation causing both a hyperpolarizing shift in activation and a
depolarizing shift in fast inactivation produces a clinical pheno-
type with characteristics of both disorders. The present results
indicate that IEMand PEPDmutations are part of a physiological
continuum that can produce a continuum
of clinical phenotypes, including IEM,
overlap disorders, and PEPD.
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